PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression

Antiviral Research
Xiaoyu ChuSongdong Meng

Abstract

In Hepatitis B virus (HBV) infection, the virus generates numerous viral mRNAs/proteins and viral loads, which plays a major role in driving T cell tolerance, viral persistence, and hepatocellular carcinoma. However, currently available anti-HBV agents have no direct effect on viral mRNA transcription and protein expression. In this study, we designed a recombinant fusion of p53 protein with the cell-penetrating peptide PTD (protein transduction domain of trans-activator of transcription), which mediated p53 internalization into hepatocytes. PTD-p53 effectively suppressed HBV transcription and antigen expression by interaction with viral enhancers. We further provide evidence that PTD-p53 counteracts the viral transcription feedback loop and effectively suppressed HBV production of viral mRNAs, as well as HBsAg, HBeAg, and HBcAg, both in vitro and in vivo. Our results thereby provide a basis for developing a new therapeutic approach against HBV infection.

References

May 2, 2002·Molecular Cell·Koji OkamotoCarol Prives
Sep 13, 2002·Journal of Viral Hepatitis·Naazneen MoollaPatrick Arbuthnot
Apr 18, 2008·Cell Cycle·Surinder M SoondAnastasis Stephanou
Apr 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Stella De MitriMauro Bernardi
Apr 20, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun-Fan Liaw
Jul 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun-Fan Liaw
Nov 23, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Saifeng WangSongdong Meng
Jan 11, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Geoffrey Dusheiko
Feb 23, 2013·World Journal of Gastroenterology : WJG·Hélène JeulinEvelyne Schvoerer
Feb 27, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christine I WooddellDavid L Lewis
Mar 1, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peixiang LanZhigang Tian
Jun 12, 2013·Seminars in Liver Disease·Dieter Glebe, Corinna M Bremer
Apr 22, 2014·Journal of Immunological Methods·Li WangXiang Zhong Liu
Apr 29, 2014·FEBS Letters·Vladimir J N Bykov, Klas G Wiman
Jun 24, 2014·Lancet·Christian TrépoAnna Lok
Oct 14, 2014·World Journal of Gastroenterology : WJG·Chan Ran YouSeung Kew Yoon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.